<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Optometry Product Guide &#187; refractive surgery</title>
	<atom:link href="http://www.optometryproductguide.com/blog/tag/refractive-surgery/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.optometryproductguide.com/blog</link>
	<description>A comprehensive guide to optometry products for medical professionals</description>
	<lastBuildDate>Fri, 11 Jun 2010 13:00:25 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.2</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>FDA permits Swiss attempt to study benefits of CXL</title>
		<link>http://www.optometryproductguide.com/blog/2008/12/02/fda-permits-swiss-attempt-to-study-benefits-of-cxl/</link>
		<comments>http://www.optometryproductguide.com/blog/2008/12/02/fda-permits-swiss-attempt-to-study-benefits-of-cxl/#comments</comments>
		<pubDate>Tue, 02 Dec 2008 09:48:47 +0000</pubDate>
		<dc:creator>Jim Marino</dc:creator>
				<category><![CDATA[Contact Lens]]></category>
		<category><![CDATA[Eyeglasses]]></category>
		<category><![CDATA[Research]]></category>
		<category><![CDATA[corneal collagen cross-linking]]></category>
		<category><![CDATA[Peschke Meditrade GmbH]]></category>
		<category><![CDATA[refractive surgery]]></category>

		<guid isPermaLink="false">http://www.optometryproductguide.com/blog/2008/12/02/fda-permits-swiss-attempt-to-study-benefits-of-cxl/</guid>
		<description><![CDATA[In a first research of its kind, the Swiss-based Peschke Meditrade GmbH has initiated a investigation to study the benefits of corneal collagen cross-linking (CXL) in subjects with progressive keratoconus and corneal ectasia after prior refractive surgery. Presently keratoconus is treated through eyeglasses, hard contact lenses, and a newer treatment, INTACS plastic rings inserted into [...]]]></description>
			<content:encoded><![CDATA[<p><img src="http://www.optometryproductguide.com/blog/wp-content/uploads/2008/12/peschke-meditrade-gmbh.png" vspace="5" width="200" align="left" height="45" hspace="5" />In a first research of its kind, the Swiss-based <a href="http://www.peschkemed.com/">Peschke Meditrade GmbH</a> has initiated a investigation to study the benefits of corneal collagen cross-linking (CXL) in subjects with progressive keratoconus and corneal ectasia after prior refractive surgery. Presently keratoconus is treated through eyeglasses, hard contact lenses, and a newer treatment, INTACS plastic rings inserted into the mid layer of the cornea to flatten it, changing the shape and location of the cone. In 15-20% of the cases, cornea transplant surgery is necessary.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.optometryproductguide.com/blog/2008/12/02/fda-permits-swiss-attempt-to-study-benefits-of-cxl/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
